SCHEMBL29133700

SCHEMBL29133700

c1ccc(CCNc2ncnc3ccc(-c4cnc5[nH]nnc5c4)cc23)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 1/20 0.56
MAPK1 P28482 7/20 0.55
LMNA P02545 6/20 0.55
HTT P42858 4/20 0.55
EGFR P00533 2/20 0.55
APP P05067 1/20 0.55
CCNC P24863 1/20 0.54
CDKN1A P38936 1/20 0.54
CDK8 P49336 1/20 0.54
CDK19 Q9BWU1 1/20 0.54
SLC29A1 Q99808 1/20 0.51
CNR1 P21554 1/20 0.51
CNR2 P34972 1/20 0.51
ALDH1A1 P00352 7/20 0.50
CYP1A2 P05177 7/20 0.50
CYP3A4 P08684 7/20 0.50
CYP2D6 P10635 7/20 0.50
HSD17B10 Q99714 7/20 0.50
CLK4 Q9HAZ1 6/20 0.50
USP2 O75604 5/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29133714 0.85 SLC29A1 (0.60) DYRK1AMAPK1LMNAHTTEGFR
SCHEMBL29133726 0.81 MAPK1 (0.61) DYRK1AMAPK1LMNAHTTEGFR
SCHEMBL29133709 0.79 EGFR (0.49) MAPK1LMNAEGFRCCNCCDKN1A
SCHEMBL29133712 0.79 MAPK1 (0.55) DYRK1AMAPK1LMNAHTTEGFR
SCHEMBL29133772 0.79 CYP1A2 (0.57) DYRK1AMAPK1LMNAHTTEGFR
SCHEMBL29133727 0.78 PIK3CA (0.65) DYRK1AMAPK1LMNAHTTEGFR
SCHEMBL29133760 0.77 DYRK1A (0.52) DYRK1AMAPK1LMNAHTTEGFR
SCHEMBL24576484 0.77 EGFR (0.64) DYRK1ALMNAEGFR
SCHEMBL29775115 0.77 EGFR (0.64) DYRK1ALMNAEGFR
SCHEMBL29133730 0.77 CLK4 (0.52) DYRK1AMAPK1LMNAHTTEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117295716-A Substituted aminobenzyl heteroaryl compounds as EGFR and/or PI3K inhibitors 麦克尼斯迪克治疗有限公司 2023-12-26 CN disclosed